Clinical Trials Browser

Has results × Breast Neoplasms × Classical hematology × Clear all

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT02728596 2022-10-20

TrACER

Phase NA Completed

3,665 enrolled 17 charts

BreastClassical hematologyGastrointestinalThoracic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Febrile Neutropenia

NCT01286987 2019-01-10

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Phase 1 Completed

113 enrolled 39 charts

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Ewing, Small Cell Lung Carcinoma

NCT02178475 2018-07-23

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Completed

943 enrolled 28 charts

BreastClassical hematology

Breast Neoplasms, Chemotherapy-Induced Febrile Neutropenia

NCT00338286 2018-03-19

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Phase 3 Completed

2,098 enrolled 12 charts

BreastClassical hematology

Anemia, Breast Neoplasms, Neoplasm Metastasis

NCT01444456 2017-03-20

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Completed

1,262 enrolled 14 charts

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicThoracic

Anemia, Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Phase 2 Completed

60 enrolled 17 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Phase 3 Completed

135 enrolled 18 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01459653 2016-01-11

Monitor-GCSF

Completed

1,496 enrolled 120 charts

BreastClassical hematologyGenitourinaryGynecologicLymphoidPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lymphoma, B-Cell, Febrile Neutropenia

NCT00676065 2014-11-19

Long-term Active Surveillance Study for Oral Contraceptives (LASS)

Completed

58,303 enrolled 11 charts

BreastClassical hematology

Breast Neoplasms, Thromboembolism, Venous Thromboembolism

Clinical Trials

ICEBERG 1

TrACER

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Monitor-GCSF

Long-term Active Surveillance Study for Oral Contraceptives (LASS)